m
Recent Posts
Connect with:
Tuesday / May 21.
HomeminewsFREE Webinar: ‘PROTECT 12 month RCT data’. NaturalVue.

FREE Webinar: ‘PROTECT 12 month RCT data’. NaturalVue.

The patients we see in our clinics often fall outside the criteria for inclusion in randomised clinical trials (RCTs), so how can we be confident that the results of a trial will be just as relevant to these patients? Comparing data from both RCTs and studies in the real world give us confidence to know we are making a fully informed decision about the intervention we choose to manage our myopic children.

Optometry Australia accreditation has been approved for: 1.25 hours Institute of Excellence Quality Assured CPD hours. This is a free webinar!

Dr Brett O’Connor will present the PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) 1-year interim RCT data from the from Visioneering Technologies Inc. ongoing multi-national, double-masked, randomised controlled trial (RCT). Dr O’Connor will share the efficacy, visual performance and safety of NaturalVue as a myopia progression intervention.

Dr Emma Gillies will present a comparison of NaturalVue 6-year data published in Clinical Ophthalmology (2022)1 and two other independent studies published in 20232,3 with the RCT data, exploring the consistency in the data in diverse study groups.

References
1. Cooper J, Aller T, Smith EL 3rd, Chan K, Dillehay SM, O’Connor B. Retrospective Analysis of a Clinical Algorithm for Managing Childhood Myopia Progression. Optom Vis Sci. 2023 Jan 1;100(1):117-124.
2. Lederman, CR. Myopia Control With Extended Depth of Focus Multifocal Contact Lenses. In: American Association for Pediatric Ophthalmology and Strabismus; 2023 Mar 29; New York, USA.
3. Walline JJ, Walker MK, Mutti DO, et al. Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA. 2020;324(6):571–580. doi:10.1001/jama.2020.10834